Isolation of inhibitory RNA aptamers against severe acute respiratory syndrome (SARS) coronavirus NTPase/Helicase
- PMID: 18082623
- PMCID: PMC7092905
- DOI: 10.1016/j.bbrc.2007.12.020
Isolation of inhibitory RNA aptamers against severe acute respiratory syndrome (SARS) coronavirus NTPase/Helicase
Abstract
Recent outbreak of Severe Acute Respiratory Syndrome (SARS) that caused almost 800 victims requires a development of efficient inhibitor against SARS coronavirus (SCV). In this study, RNA aptamers against SCV NTPase/Helicase (nsP10) were isolated from RNA library containing random sequences of 40 nts using in vitro selection technique. Nucleotide sequences of enriched RNA aptamer pool (ES15 RNA) contain AG-rich conserved sequence of 10-11 nucleotides [AAAGGR(G)GAAG; R, purine base] and/or additional sequence of 5 nucleotides [GAAAG], which mainly reside at the loop region in all the predicted secondary structures. Isolated RNAs were observed to efficiently inhibit double-stranded DNA unwinding activity of the helicase by up to approximately 85% with an IC(50) value of 1.2nM but show a slight effect on ATPase activity of the protein in the presence of cofactor, poly (rU). These results suggest that the pool of selected aptamers might be potentially useful as anti-SCV agents.
Figures




Similar articles
-
The severe acute respiratory syndrome (SARS) coronavirus NTPase/helicase belongs to a distinct class of 5' to 3' viral helicases.J Biol Chem. 2003 Oct 10;278(41):39578-82. doi: 10.1074/jbc.C300328200. Epub 2003 Aug 13. J Biol Chem. 2003. PMID: 12917423 Free PMC article.
-
Differential inhibitory activities and stabilisation of DNA aptamers against the SARS coronavirus helicase.Chembiochem. 2008 Dec 15;9(18):3037-45. doi: 10.1002/cbic.200800491. Chembiochem. 2008. PMID: 19031435 Free PMC article.
-
SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts.Virol Sin. 2020 Jun;35(3):321-329. doi: 10.1007/s12250-020-00242-1. Epub 2020 Jun 4. Virol Sin. 2020. PMID: 32500504 Free PMC article.
-
Development of chemical inhibitors of the SARS coronavirus: viral helicase as a potential target.Biochem Pharmacol. 2012 Nov 15;84(10):1351-8. doi: 10.1016/j.bcp.2012.08.012. Epub 2012 Aug 23. Biochem Pharmacol. 2012. PMID: 22935448 Free PMC article. Review.
-
Synthesis of novel test compounds for antiviral chemotherapy of severe acute respiratory syndrome (SARS).Curr Med Chem. 2005;12(18):2095-162. doi: 10.2174/0929867054637644. Curr Med Chem. 2005. PMID: 16101496 Review.
Cited by
-
Cooperative translocation enhances the unwinding of duplex DNA by SARS coronavirus helicase nsP13.Nucleic Acids Res. 2010 Nov;38(21):7626-36. doi: 10.1093/nar/gkq647. Epub 2010 Jul 29. Nucleic Acids Res. 2010. PMID: 20671029 Free PMC article.
-
Nucleic acid aptamer-based methods for diagnosis of infections.Biosens Bioelectron. 2018 Apr 15;102:179-188. doi: 10.1016/j.bios.2017.11.028. Epub 2017 Nov 8. Biosens Bioelectron. 2018. PMID: 29136589 Free PMC article. Review.
-
Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses.Pharmaceuticals (Basel). 2016 Dec 16;9(4):78. doi: 10.3390/ph9040078. Pharmaceuticals (Basel). 2016. PMID: 27999271 Free PMC article. Review.
-
Blood-based biomarkers for diagnosis, prognosis, and severity prediction of COVID-19: Opportunities and challenges.J Family Med Prim Care. 2022 Aug;11(8):4330-4341. doi: 10.4103/jfmpc.jfmpc_2283_21. Epub 2022 Aug 30. J Family Med Prim Care. 2022. PMID: 36352911 Free PMC article. Review.
-
An updated analysis of variations in SARS-CoV-2 genome.Turk J Biol. 2020 Jun 21;44(3):157-167. doi: 10.3906/biy-2005-111. eCollection 2020. Turk J Biol. 2020. PMID: 32595352 Free PMC article.
References
-
- World Health Organization, Summary of probable SARS cases with onset of illness from 1st November 2002 to 31st July 2003, http://www.who.int/csr/sars/country/ (2003).
-
- Marra M.A. The Genome sequence of the SARS-associated coronavirus. Science. 2003;300:1399–1404. - PubMed
-
- Rota P.A. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 2003;300:1394–1399. - PubMed
-
- Bacha U., Barrila J., Velazquez-Campoy A., Leavitt S.A., Freire E. Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro. Biochemistry. 2004;43:4906–4912. - PubMed
-
- Anand K., Ziebuhr J., Wadhwani P., Mesters J.R., Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science. 2003;300:1763–1767. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous